A report by the Massachusetts Department of Public Health (DPH) shows a strong correlation between hazardous jobs and opiate addiction and overdoses in that state. The 21-page study titled Opioid-related Overdose Deaths in Massachusetts by Industry and Occupation, 2011-2015 found that there were a total of 5,580 opioid-related overdose deaths in Massachusetts from 2011 through 2015. Of the 4,284 worker death certificates deemed comprehensive enough to study, 1,096 were found to be employed in construction/extraction.

New restrictions on how long injured federal workers can get prescription opioids have been implemented by the DOL's Office of Workers' Compensation Programs, as a way of protecting the workers from the risks of long-term opioid use. The DOL controls – which impose a 7-day limit on the initial fill of an opioid prescription - will apply to injured federal workers receiving benefits under the Federal Employees' Compensation Act.

Lorraine M. Martin, NSC president and CEO, and Joseph A. Reuter, Stericycle executive vice president and chief people officer, spoke to the media Monday morning to discuss the NSC’s new Opioids at Work Employer Toolkit. The toolkit, which will officially be released on September 18, includes more than two dozen resources for four specific groups found in a typical workplace setting: supervisors, HR professionals, safety professionals and employees.

In the study, “Suicide and drug‐related mortality following occupational injury,” published in the American Journal of Industrial Medicine, researchers found that workplace injury significantly raises a person’s risk of suicide or overdose death. Earlier studies have shown that injured workers have elevated rates opioid use and depression.

Dueling ads currently playing out on the nation’s TV screens show both sides in an escalating conflict involving manufacturers, health experts and federal regulators. PSAs produced by the FDA warn American children about the dangers of e-cigarette use, or vaping. Meanwhile, e-cigarettes – whose makers have so far managed to evade the ban on tobacco advertising, despite the fact that the devices contain tobacco – are portrayed as health aids which can assist smokers in quitting the use of conventional cigarettes.

The numbers are staggering: 76 billion pain pills distributed between 2006 and 2012 by the largest drugs companies in the U.S. Enough to supply every child and adult in the country with 36 pills each year. In the hardest hit rural communities, the pill-per-capita count reached into the hundreds.

The Food and Drug Administration (FDA) is developing new guidance intended to help make people fully aware of the abuse or addiction possibilities of the prescriptions they’re taking. Drug Abuse and Dependence Section of Labeling for Human Prescription Drug and Biological Products - Content and Format doesn’t just deal with prescription medications that are scheduled under the Controlled Substances Act (CSA). Medications not scheduled under the CSA that have dependence potential are also addressed.

Solving the opioid epidemic requires a “whole person” approach that includes nonpharmacological treatment for pain, as well as ensuring that people have the employment, education and housing supports they need for long-term recovery, the chief executive officer of the American Psychological Association (APA) told a congressional panel.

The opioid overdose epidemic continues to claim lives across the country with a record 47,600 overdose deaths in 2017[i]. The crisis is taking an especially devastating toll on certain parts of the U.S. workforce. High rates of opioid overdose deaths have occurred in industries with high injury rates and physically demanding working conditions such as construction, mining, or fishing[ii],[iii].

The National Institutes of Health (NIH) is warning of a “converging public health crisis,” as the nation’s opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections. Infectious disease and substance use disorder professionals must work together to stem the mounting public health threat, according to a new commentary in the Journal of Infectious Diseases.